Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus

August 26, 2020 updated by: Amira M elSonbaty, Assiut University
This study aims to evaluate the rule of NMUS in detection of peripheral neuropathy in SLE patient and to correlate it to traditional neurophysiological studies, clinical signs and activity of SLE.

Study Overview

Detailed Description

The frequency of SLE peripheral neuropathy documented by electrophysiology has been estimated to be approximately 30%.

The term peripheral neuropathies include symmetric polyneuropathy, single and multiple mononeuropathy, and radiculopathy.

There has been increasing interest in using ultrasonography (US) to aid peripheral neuropathy diagnosis and studies have shown good correlation with other imaging modalities. US is a non-invasive and inexpensive imaging device that has become widely available as a diagnostic tool at many fields.

so systemic lupus patients were enrolled in the study , performed nerve conduction study and neuromuscular ultrasound for bil. median, ulnar, peroneal, tibial and sural nerves , on statistics the cross sections were compared in neurophusiologically affected and non affected nerves, also the sensitivity and specifity of NMUS in comparison to the traditional NCS was calculated

Study Type

Observational

Enrollment (Actual)

55

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Assiut, Egypt, 12222
        • Assuit University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All adult SLE patientA who was admitted to Rheumatology & Rehabilitation department of Assuit university hospital during time frame of study. and apparently healthy subjects with normal electrophysiological study

Description

Inclusion Criteria:

  1. All adult SLE patients who was admitted to Rheumatology & Rehabilitation department of Assuit university hospital during time frame of study.
  2. apparently healthy subjects with normal electrophysiological study
  3. verbal consent, free and informed

Exclusion Criteria:

  • • Other causes of peripheral neuropathy:

    1. Traumatic
    2. Purely degenerative
    3. Diabetic
    4. Toxic
    5. Infections
    6. Drug induced

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
systemic lupus patients
Nerve conduction study and neuromuscular ultrasound for median , ulnar, tibial, peroneal and sural nerves
ultrasound to visualize the peripheral nerves of lupus patients and to compare it with results of the raditional electrophysiological studies
Other Names:
  • nerve conduction study
Healthy subjects
Nerve conduction study and neuromuscular ultrasound for median , ulnar, tibial, peroneal and sural nerves
ultrasound to visualize the peripheral nerves of lupus patients and to compare it with results of the raditional electrophysiological studies
Other Names:
  • nerve conduction study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
evaluate the rule of NMUS in detection of peripheral neuropathy in SLE patient
Time Frame: 6months
Measuring sensitivity and specificity of neuromuscular ultrasound in comparison to nerve conduction study
6months
Describing the patterns of peripheral nerve affection in SLE patient
Time Frame: 6months
Evaluating different studied nerves clinically, electrophyiologically and by neuromuscular ultrasonography
6months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Tayseer Khedr, PHD, Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 20, 2018

Primary Completion (ACTUAL)

May 28, 2019

Study Completion (ACTUAL)

May 15, 2020

Study Registration Dates

First Submitted

August 22, 2020

First Submitted That Met QC Criteria

August 25, 2020

First Posted (ACTUAL)

August 26, 2020

Study Record Updates

Last Update Posted (ACTUAL)

August 28, 2020

Last Update Submitted That Met QC Criteria

August 26, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

the priciple investigator only will know the results of neurophysiology done to the patients then the images were furtherly evaluated (offline) by another expert rheumatologist who was blinded to both clinical and electrophysiological data of the patients. Any conflict in reporting was refered to a third expert rheumatologist to put the final decision.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Neuropathy

Clinical Trials on neuromuscular ultrasound

3
Subscribe